Neoadjuvant cabozantinib plus nivolumab before cytoreductive nephrectomy shows promising responses in metastatic clear cell RCC

ASCO GU 2026: Updates in renal cancer

ASCO GU 2026: Updates in bladder cancer

ASCO GU 2026: Updates in metastatic prostate cancer

ASCO GU 2026: Updates in localised prostate cancer

Post-orchiectomy miR-371 predicts recurrence in clinical stage I testicular germ cell tumours during active surveillance

Epcoritamab plus rituximab and lenalidomide improves efficacy in relapsed or refractory follicular lymphoma

Tepotinib in second line NSCLC treatment

Zanidatamab improves PFS and OS in first-line HER2-positive metastatic gastric cancer

Consolidation treatment delays do not compromise survival in MRD-negative adult ALL

Dasatinib, prednisone, and blinatumomab combination shows promising outcomes in elderly patients with Ph+ ALL

Tec-Dara significantly improves PFS and OS compared to SoC in relapsed/refractory multiple myeloma